Warmuth, M. and Nachtnebel, A. (2012): Radiofrequency ablation of tumours of the lung and mediastinal lymph nodes. Decision Support Document 53.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
Radiofrequency ablation (RFA) is a relatively new, minimally-invasive ablation method that destroys tumours by local application of heat.
In terms of RFA for the treatment of lung tumours, we included one randomised controlled trial and ten prospective case-series. According to GRADE, the quality of evidence of the included RCT is very low due to major methodological flaws. Moreover, the quality of evidence of the included case-series is very low due their uncontrolled study design. Overall, the available evidence is insufficient to assess the efficacy and safety of RFA compared to the respective standard therapy for the treatment of lung tumours. Furthermore, there is no evidence regarding RFA for the treatment of tumours of mediastinal lymph nodes.
|Item Type:||Decision Support Document|
|Keywords:||Radiofrequency ablation, lung tumor, lung tumour, non-small cell lung cancer, NSCLC, mediastinal lymph nodes, minimally-invasive surgical procedure|
|Subjects:||WO Surgery > WO 500-517 Operative surgical procedures. Techniques|
WH Hemic and lymphatic systems
WF Respiratory system
WO Surgery > WO 505 Minimally invasive surgical procedures
|Series Name:||Decision Support Document 53|
|Deposited on:||23 Jul 2012 19:51|
|Last Modified:||23 Jul 2012 19:51|
Repository Staff Only: item control page